Palliation

ASCO Journal Club

Journal Club Q&A done in partnership with ASCO the Journal of Clinical Oncology

Questions discussed in this category

How do you present the trade off between a small chance of a sustained response for a new drug at the expense of potential worsening quality of life?

1 Answer available

Has precision medicine changed how you consent patients for treatment?

1 Answer available

When discussing immunotherapy with patients, how do you frame the conversation in a way that acknowledges the fact that many patients do not respond but allows for hope for a durable response?

1 Answer available

Related Topics in Palliation